Can you Afford to Not Consider the Importance of Informatics in Your Global Temperature Controlled Supply Chain?

Fri, Apr 05, 2019 | By Soren H. Knudsen, Commercial Director, EMEA, Cryoport

The number of clinical trials is increasing: There are more than 275,000 registered on, a 26 percent increase from the year 2000.

Escalating costs and delays in clinical trials for new drugs and treatments remains common in the industry. In fact, one of the key challenges for the Pharmaceutical and Life Sciences industries remains to be “time to market.” According to a white paper by InterSystems, close to 50% of all delays are caused by patient recruitment issues resulting from lack of access to and use of real-world data to reduce this. 

soren blog graph image

In order to reverse this trend, real world data to support the questions around:

  • Protocol feasibility
  • Site selection
  • Patient recruitment
  • Observational studies

must be used and addressed. While the above may seem simple, arriving at the answers are complex and with significant obstacles often standing in the way.

In much the same way – to avoid adding further delays down the line – considerations around global cold chain Informatics on your logistical supply chain are just as important.

live view-1

To understand and simplify the complexity of Cold Chain Logistics, Cryoport provides a fully integrated approach, centered around four pillars:

  • Packaging
    • Equipment and technology designed and manufactured specifically for the task
  • Condition Monitoring
    • Processes, near real-time informatics and systems that eliminate risk of temperature excursions; including intervention capabilities
  • Information Technology
    • Ensuring the most advanced Logistic Management Platform (Cryoportal®) for fast order entry, condition monitoring and customs paperwork
  • Logistic Expertise
    • Flawlessly executed defined Standard Operating Procedures, knowledgeable, action-oriented and extensively trained to take appropriate action, 24/7/365.

At Cryoport, we understand the complexity of the regenerative medicine field, supporting more than 350 clinical trials globally. We deploy state of the art Condition Monitoring Systems such as the SmartPakII™ which - in conjunction with our CryoPortal® logistics management platform - provides you with near real-time reporting on your shipments, integrating condition monitoring, logistics and shipper qualification performance in a single data stream. Simultaneously our informatics allows us to proactively intervene and avoid unnecessary carrier and other hold delays enroute.

Our systems have the ability to maximize equipment utilization through superior return logistics. This reduces the capital costs of the client’s fleets.  Additionally, Cryoport has the ability to customize solutions based on need and provide dedicated fleet options for commercial launch needs.

Cryoport. Transporting Life.             

Written by: Soren H. Knudsen, Commercial Director, EMEA, Cryoport

Read our blog for the latest news on cold chain logistics issues.

Questions or comments? We welcome your feedback!

Email Us

Tags: Frozen Shipping, frozen shipping solution, Cold Chain Logistics, Cold Chain, Clinical Trials Logistics, Global Cold Chain Logistics, alternative to dry ice shipping, stem cell frozen shipping, regenerative therapies, deep frozen shipping, cellular therapies, Temperature Controlled Logistics, cryogenic shipping, cold chain shipping, biologics, transportation, Chain of Compliance®

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC